India: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in India

The Indian market for other medicaments for therapeutic or prophylactic uses amounted to $X in 2022, therefore, remained relatively stable against the previous year. The market value increased at an average annual rate of X% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. Consumption of peaked at $X in 2019; however, from 2020 to 2022, consumption stood at a somewhat lower figure.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in India

In value terms, production of other medicaments for therapeutic or prophylactic uses fell slightly to $X in 2022 estimated in export price. Over the period under review, production, however, continues to indicate a relatively flat trend pattern. The pace of growth was the most pronounced in 2015 with an increase of X% against the previous year. Over the period under review, production of hit record highs at $X in 2019; however, from 2020 to 2022, production remained at a lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from India

After two years of growth, shipments abroad of other medicaments for therapeutic or prophylactic uses decreased by X% to X tons in 2022. Over the period under review, total exports indicated prominent growth from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by X% against 2019 indices. The most prominent rate of growth was recorded in 2021 when exports increased by X% against the previous year. As a result, the exports reached the peak of X tons, and then fell slightly in the following year.

In value terms, exports of other medicaments for therapeutic or prophylactic uses shrank to $X in 2022. In general, exports saw a slight reduction. The pace of growth was the most pronounced in 2021 with an increase of X% against the previous year. Over the period under review, the exports of attained the maximum at $X in 2012; however, from 2013 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

The United States (X tons), Spain (X tons) and Belgium (X tons) were the main destinations of exports of other medicaments for therapeutic or prophylactic uses from India, with a combined X% share of total exports.

From 2012 to 2022, the biggest increases were recorded for Belgium (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the United States ($X) remains the key foreign market for other medicaments for therapeutic or prophylactic uses exports from India, comprising X% of total exports. The second position in the ranking was held by Germany ($X), with a X% share of total exports. It was followed by Spain, with a X% share.

From 2012 to 2022, the average annual growth rate of value to the United States totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Germany (X% per year) and Spain (X% per year).

Export Prices by Country

The average export price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, approximately equating the previous year. Overall, the export price saw a abrupt setback. The pace of growth appeared the most rapid in 2018 an increase of X% against the previous year. The export price peaked at $X per ton in 2012; however, from 2013 to 2022, the export prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Germany ($X per ton), while the average price for exports to Sri Lanka ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Sri Lanka (X%), while the prices for the other major destinations experienced a decline.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into India

For the seventh year in a row, India recorded growth in overseas purchases of other medicaments for therapeutic or prophylactic uses, which increased by X% to X tons in 2022. Overall, imports posted a significant expansion. The most prominent rate of growth was recorded in 2021 with an increase of X% against the previous year. Over the period under review, imports of reached the maximum in 2022 and are expected to retain growth in the near future.

In value terms, imports of other medicaments for therapeutic or prophylactic uses surged to $X in 2022. In general, imports showed a resilient expansion. The pace of growth was the most pronounced in 2016 when imports increased by X%. Over the period under review, imports of reached the peak figure in 2022 and are expected to retain growth in the immediate term.

Imports by Country

In 2022, Canada (X tons) constituted the largest other medicaments for therapeutic or prophylactic uses supplier to India, with a X% share of total imports. Moreover, imports of other medicaments for therapeutic or prophylactic uses from Canada exceeded the figures recorded by the second-largest supplier, the Netherlands (X tons), twofold. The third position in this ranking was taken by Nepal (X tons), with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from Canada totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: the Netherlands (X% per year) and Nepal (X% per year).

In value terms, Germany ($X), Canada ($X) and China ($X) were the largest other medicaments for therapeutic or prophylactic uses suppliers to India, together comprising X% of total imports.

Canada, with a CAGR of X%, recorded the highest growth rate of the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average import price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, waning by X% against the previous year. In general, the import price faced a drastic downturn. The most prominent rate of growth was recorded in 2016 an increase of X% against the previous year. As a result, import price attained the peak level of $X per ton. From 2017 to 2022, the average import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Germany ($X per ton), while the price for Canada ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Germany (X%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :